Aadi Bioscience Files 8-K on Shareholder Vote Matters

TL;DR

AADI is asking shareholders to vote on important stuff, stay tuned.

AI Summary

On June 11, 2024, Aadi Bioscience, Inc. filed an 8-K report detailing the submission of matters to a vote of its security holders. The filing indicates that the company is seeking approval from its shareholders on certain proposals, the specifics of which are not detailed in this summary but are crucial for the company's ongoing operations and strategic decisions.

Why It Matters

This filing signals that Aadi Bioscience is engaging its shareholders in key corporate decisions, which could impact the company's future direction and governance.

Risk Assessment

Risk Level: medium — Shareholder votes can introduce uncertainty regarding corporate actions and strategic approvals.

Key Players & Entities

• Aadi Bioscience, Inc. (company) — Registrant
• June 11, 2024 (date) — Date of earliest event reported
• Delaware (jurisdiction) — State of incorporation
• 17383 Sunset Boulevard, Suite A250 (address) — Principal executive offices
• Pacific Palisades, California 90272 (address) — Principal executive offices

FAQ

Key Financial Figures

• $0.0001 — ch registered Common Stock, par value $0.0001 per share AADI The Nasdaq Stock Marke

Filing Documents

• aadi-20240611.htm (8-K) — 37KB
• 0001628280-24-027826.txt ( ) — 161KB
• aadi-20240611.xsd (EX-101.SCH) — 2KB
• aadi-20240611_lab.xml (EX-101.LAB) — 22KB
• aadi-20240611_pre.xml (EX-101.PRE) — 13KB
• aadi-20240611_htm.xml (XML) — 3KB

07. Submission of Matters to a Vote of Security Holders

Item 5.07. Submission of Matters to a Vote of Security Holders. Aadi Bioscience, Inc. (the " Company ") held its annual meeting of stockholders on June 11, 2024 (the " Annual Meeting "). At the Annual Meeting, 15,104,613 shares of common stock of the Company, representing approximately 62% of the voting power of all issued and outstanding shares of common stock of the Company as of April 18, 2024, the record date for the Annual Meeting, and constituting a quorum for the transaction of business, were present in person or by proxy and considered and voted on the following proposals, each of which is described in more detail in the Company's definitive proxy statement for the Annual Meeting filed with the Securities and Exchange Commission on April 26, 2024 (the " Proxy Statement "): (1) the election of two Class I directors for terms to expire at the Company's 2027 annual meeting of stockholders and until their respective successors have been duly elected and qualified; (2) on an advisory basis, the compensation of the named executive officers identified in the 2023 Summary Compensation Table in the "Executive Compensation" section of the Proxy Statement; and (3) the ratification of the appointment of BDO USA LLP as the Company's independent registered public accounting firm for the current fiscal year ending December 31, 2024. The voting results at the Annual Meeting with respect to each of the matters described above were as follows: Proposal 1: Election of two Class I directors to serve until the 2027 Annual Meeting of Stockholders and until their respective successors have been elected or qualified. Director For Withheld Broker Non-Votes Caley Castelein, M.D. 9,946,929 1,906,524 3,251,160 Neil Desai, Ph.D. 8,171,610 3,681,843 3,251,160 Proposal 2: To approve, on an advisory basis, the compensation of the named executive officers identified in the 2023 Summary Compensation Table in the "Executive Compensation" section of the Proxy Statement. For Again

SIGNATURES

SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. June 12, 2024 /s/ Scott Giacobello Scott Giacobello Chief Financial Officer

View Full Filing

View this 8-K filing on SEC EDGAR